These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26746121)

  • 1. Efficacy of Low-Dose Buspirone for Restricted and Repetitive Behavior in Young Children with Autism Spectrum Disorder: A Randomized Trial.
    Chugani DC; Chugani HT; Wiznitzer M; Parikh S; Evans PA; Hansen RL; Nass R; Janisse JJ; Dixon-Thomas P; Behen M; Rothermel R; Parker JS; Kumar A; Muzik O; Edwards DJ; Hirtz D;
    J Pediatr; 2016 Mar; 170():45-53.e1-4. PubMed ID: 26746121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
    Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
    Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized double-blind placebo-controlled clinical trial of adjuvant buspirone for irritability in autism.
    Ghanizadeh A; Ayoobzadehshirazi A
    Pediatr Neurol; 2015 Jan; 52(1):77-81. PubMed ID: 25451017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An 8-week, randomized controlled trial of atomoxetine, atomoxetine plus buspirone, or placebo in adults with ADHD.
    Sutherland SM; Adler LA; Chen C; Smith MD; Feltner DE
    J Clin Psychiatry; 2012 Apr; 73(4):445-50. PubMed ID: 22313788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.
    McRae-Clark AL; Baker NL; Gray KM; Killeen TK; Wagner AM; Brady KT; DeVane CL; Norton J
    Drug Alcohol Depend; 2015 Nov; 156():29-37. PubMed ID: 26386827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo.
    Landén M; Eriksson O; Sundblad C; Andersch B; Naessén T; Eriksson E
    Psychopharmacology (Berl); 2001 May; 155(3):292-8. PubMed ID: 11432692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, effectiveness, and economic evaluation of an herbal medicine, Ukgansangajinpibanha granule, in children with autism spectrum disorder: a study protocol for a prospective, multicenter, randomized, double-blinded, placebo-controlled, parallel-group clinical trial.
    Lee SH; Shin S; Kim TH; Kim SM; Do TY; Park S; Lee B; Shin HJ; Lee J; Lee JY; Chang GT
    Trials; 2019 Jul; 20(1):434. PubMed ID: 31307524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
    Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
    J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective Chart Review of Buspirone for the Treatment of Anxiety in Psychiatrically Referred Youth with High-Functioning Autism Spectrum Disorder.
    Ceranoglu TA; Wozniak J; Fried R; Galdo M; Hoskova B; DeLeon Fong M; Biederman J; Joshi G
    J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):28-33. PubMed ID: 30452283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folinic acid improves the score of Autism in the EFFET placebo-controlled randomized trial.
    Renard E; Leheup B; Guéant-Rodriguez RM; Oussalah A; Quadros EV; Guéant JL
    Biochimie; 2020 Jun; 173():57-61. PubMed ID: 32387472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of restricted/repetitive behavior in autism spectrum disorder:a systematic review and meta-analysis.
    Yu Y; Chaulagain A; Pedersen SA; Lydersen S; Leventhal BL; Szatmari P; Aleksic B; Ozaki N; Skokauskas N
    BMC Psychiatry; 2020 Mar; 20(1):121. PubMed ID: 32164636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid treatment for autism: a proof-of-concept randomized trial.
    Aran A; Harel M; Cassuto H; Polyansky L; Schnapp A; Wattad N; Shmueli D; Golan D; Castellanos FX
    Mol Autism; 2021 Feb; 12(1):6. PubMed ID: 33536055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study.
    Sumiyoshi T; Park S; Jayathilake K; Roy A; Ertugrul A; Meltzer HY
    Schizophr Res; 2007 Sep; 95(1-3):158-68. PubMed ID: 17628435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Previous Exposure to Anesthesia and Autism Spectrum Disorder (ASD): A Puerto Rican Population-Based Sibling Cohort Study.
    Creagh O; Torres H; Rivera K; Morales-Franqui M; Altieri-Acevedo G; Warner D
    Bol Asoc Med P R; 2015; 107(3):29-37. PubMed ID: 26742193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, Placebo-Controlled Trial of Methyl B12 for Children with Autism.
    Hendren RL; James SJ; Widjaja F; Lawton B; Rosenblatt A; Bent S
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):774-783. PubMed ID: 26889605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder.
    Scahill L; McCracken JT; King BH; Rockhill C; Shah B; Politte L; Sanders R; Minjarez M; Cowen J; Mullett J; Page C; Ward D; Deng Y; Loo S; Dziura J; McDougle CJ;
    Am J Psychiatry; 2015 Dec; 172(12):1197-206. PubMed ID: 26315981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world.
    Winhusen T; Brady KT; Stitzer M; Woody G; Lindblad R; Kropp F; Brigham G; Liu D; Sparenborg S; Sharma G; Vanveldhuisen P; Adinoff B; Somoza E
    Contemp Clin Trials; 2012 Sep; 33(5):993-1002. PubMed ID: 22613054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism.
    Mankad D; Dupuis A; Smile S; Roberts W; Brian J; Lui T; Genore L; Zaghloul D; Iaboni A; Marcon PM; Anagnostou E
    Mol Autism; 2015; 6():18. PubMed ID: 25798215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.
    Lemonnier E; Villeneuve N; Sonie S; Serret S; Rosier A; Roue M; Brosset P; Viellard M; Bernoux D; Rondeau S; Thummler S; Ravel D; Ben-Ari Y
    Transl Psychiatry; 2017 Mar; 7(3):e1056. PubMed ID: 28291262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Efficacy of Buspirone and Placebo in Childhood Functional Abdominal Pain: A Randomized Clinical Trial.
    Badihian N; Yaghini O; Badihian S; Shahsanai A; Saneian H
    Am J Gastroenterol; 2020 May; 115(5):756-765. PubMed ID: 32221160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.